India to Philippines: Trastuzumab Export Trade Route
India has recorded 19 verified shipments of Trastuzumab exported to Philippines, representing a combined trade value of $2.5M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $130.7K USD. The leading Indian exporter is BIOCON BIOLOGICS INDIA LIMITED, which accounts for 61% of total export value with 9 shipments worth $1.5M USD. On the buying side, BIOCON BIOLOGICS UK LIMITED is the largest importer in Philippines with $1.0M USD in purchases. The top 3 suppliers — BIOCON BIOLOGICS INDIA LIMITED, CHANDRA BHAGAT PHARMA LIMITED, RMPL PHARMA LLP — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Trastuzumab corridor is one of India's established pharmaceutical export routes, with 19 shipments documented worth a combined $2.5M USD. The route is dominated by BIOCON BIOLOGICS INDIA LIMITED, which alone accounts for roughly 61% of all export value, reflecting the consolidated nature of India's trastuzumab manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $130.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 26.6%, placing it at rank #11 among India's top trastuzumab export destinations globally.
On the import side, key buyers of Indian trastuzumab in Philippines include BIOCON BIOLOGICS UK LIMITED, TO BANK OF THE PHILIPPINE ISLANDS, XXOCOXXBIOXXGICXXUK XXMITXX and 3 others. BIOCON BIOLOGICS UK LIMITED is the single largest importer with 6 shipments valued at $1.0M USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#11
- Annual growth+26.6%
- Demand growth+22.4%
- Regulatory ease69/100
Top 10 Indian Trastuzumab Exporters to Philippines
Showing top 10 of 4 Indian suppliers exporting Trastuzumab to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOCON BIOLOGICS INDIA LIMITED Avg $168.0K per shipment | 9 | $1.5M | 60.9% |
| 2 | CHANDRA BHAGAT PHARMA LIMITED Avg $161.7K per shipment | 6 | $970.4K | 39.1% |
| 3 | RMPL PHARMA LLP Avg $609 per shipment | 2 | $1.2K | 0.0% |
| 4 | INTAS PHARMACEUTICALS LIMITED Avg $3 per shipment | 2 | $5 | 0.0% |
This table shows the top 10 of 4 Indian companies exporting trastuzumab to Philippines, ranked by total trade value. The listed exporters are: BIOCON BIOLOGICS INDIA LIMITED, CHANDRA BHAGAT PHARMA LIMITED, RMPL PHARMA LLP , INTAS PHARMACEUTICALS LIMITED. BIOCON BIOLOGICS INDIA LIMITED is the dominant supplier with 9 shipments worth $1.5M USD, giving it a 61% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Trastuzumab Importers in Philippines
Showing top 10 of 6 known buyers in Philippines receiving Trastuzumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian trastuzumab in Philippines include BIOCON BIOLOGICS UK LIMITED, TO BANK OF THE PHILIPPINE ISLANDS, XXOCOXXBIOXXGICXXUK XXMITXX, TO THE ORDER, TO THE ORDER OF INVOICE RAISED TO , among 6 total buyers. The largest importer is BIOCON BIOLOGICS UK LIMITED, accounting for $1.0M USD across 6 shipments — representing 41% of all trastuzumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOCON BIOLOGICS UK LIMITED | 6 | $1.0M | 40.7% |
| 2 | TO BANK OF THE PHILIPPINE ISLANDS | 4 | $675.9K | 27.2% |
| 3 | XXOCOXXBIOXXGICXXUK XXMITXX | 3 | $501.3K | 20.2% |
| 4 | TO THE ORDER | 2 | $294.4K | 11.9% |
| 5 | TO THE ORDER OF INVOICE RAISED TO | 2 | $1.2K | 0.0% |
| 6 | ONE DEXCEL PHARMA INC | 2 | $5 | 0.0% |
Top 10 Trastuzumab Formulations Imported by Philippines
Showing top 10 of 14 product formulations shipped on the India to Philippines Trastuzumab route, ranked by trade value
Philippines imports a wide range of trastuzumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TRASTUZUMAB FOR INJECTION RDNA — accounts for $398.6K USD across 2 shipments. There are 14 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TRASTUZUMAB FOR INJECTION RDNA | 2 | $398.6K | 16.0% |
| 2 | TRASTUZUMAB FOR INJECTION | 2 | $306.9K | 12.4% |
| 3 | TRASTUZUMAB FOR INJECTION(RDNA | 2 | $305.6K | 12.3% |
| 4 | TRASTUZUMAB FOR INJECTIONRDNA | 2 | $305.5K | 12.3% |
| 5 | PHARMACEUTICAL PRODUCTS - (HERTHIX)TRASTUZUMAB LYOPHILIZED POWDER FORSOLUTION FOR INFUSION (IV) 150 MG | 1 | $234.9K | 9.5% |
| 6 | TRASTUZUMAB FOR INJECTION RDNA | 1 | $195.6K | 7.9% |
| 7 | PHARMA PROD.HARMLESS MEDICINE FOR HUMANCONSUMPTION HERTHIX) TRASTUZUMABLYOPHILIZED POWDER FOR SOLUTIONS | 1 | $176.7K | 7.1% |
| 8 | PHARMACEUTICAL PRODUCTS HARMLESSMEDICINE FOR HUMAN CONSUMPTION (TRASTUMED) TRASTUZUMAB LYOPHILIZED POWDER FOR | 1 | $159.6K | 6.4% |
| 9 | PHARMACEUTICALS PRODUCTS HARMLESS MEDICINE FOR HUMAN CONSUMPTION (TRASTUMED) TRASTUZUMAB LYOPHILIZED POWDER FOR SOLUTION | 1 | $150.3K | 6.0% |
| 10 | PHARMACEUTICAL PRO.HARMLESS MEDICINE FORHUMAN CONSUMPTION-(SADIA) TRASTUZUMAB LYOPHILIZED POWDER FOR SOLUTION FOR | 1 | $131.2K | 5.3% |
Showing top 10 of 14 Trastuzumab formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 4 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's trastuzumab exports to Philippines are driven primarily by a handful of large-scale manufacturers. BIOCON BIOLOGICS INDIA LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — BIOCON BIOLOGICS INDIA LIMITED, CHANDRA BHAGAT PHARMA LIMITED, RMPL PHARMA LLP — together account for 100% of total trade value on this route. The average shipment value of $130.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as trastuzumab for injection and trastuzumab for injection(rdna, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BIOCON BIOLOGICS UK LIMITED is the largest importer with 6 shipments worth $1.0M USD — representing 41% of all trastuzumab imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.5M
- Avg. Shipment
- $130.7K
- Suppliers
- 4
- Buyers
- 6
- Transit (Sea)
- ~16 days
- Annual Growth
- +26.6%
Related Analysis
Other Trastuzumab Routes
Unlock the Full India to Philippines Trastuzumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 19 shipments on this route.
Frequently Asked Questions — India to Philippines Trastuzumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Trastuzumab to Philippines?
The leading Indian exporters of Trastuzumab to Philippines are BIOCON BIOLOGICS INDIA LIMITED, CHANDRA BHAGAT PHARMA LIMITED, RMPL PHARMA LLP . BIOCON BIOLOGICS INDIA LIMITED holds the largest market share at approximately 61% of total trade value on this route.
Q What is the total value of Trastuzumab exports from India to Philippines?
India exports Trastuzumab to Philippines worth approximately $2.5M USD across 19 recorded shipments. The average value per shipment is $130.7K USD.
Q Which ports does India use to ship Trastuzumab to Philippines?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 4 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Philippines for Trastuzumab?
The average transit time for Trastuzumab shipments from India to Philippines is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Philippines Trastuzumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.6% with demand growth tracking at 22.4%. The route is ranked #11 among India's top Trastuzumab export destinations globally.
Q How many suppliers are active on the India to Philippines Trastuzumab route?
There are currently 4 active Indian suppliers exporting Trastuzumab to Philippines. The market is moderately concentrated with BIOCON BIOLOGICS INDIA LIMITED accounting for 61% of total shipment value.
Q Who are the main importers of Trastuzumab from India in Philippines?
The leading importers of Indian Trastuzumab in Philippines include BIOCON BIOLOGICS UK LIMITED, TO BANK OF THE PHILIPPINE ISLANDS, XXOCOXXBIOXXGICXXUK XXMITXX, TO THE ORDER, TO THE ORDER OF INVOICE RAISED TO . BIOCON BIOLOGICS UK LIMITED is the largest buyer with 6 shipments worth $1.0M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Trastuzumab.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 6 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 19 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
19 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists